Abstract

Private investors have a lot to offer universities who are interested in developing and commercializing new technologies. Michael N. Helmus and Anil K. Rao describe how such partnerships can work in practice.

1. Michael N. Helmus is a consultant working in the areas of biomaterials, nanotechnology, medical devices and controlled drug delivery.
   e-mail: mhelmus571@aol.com
2. Anil K. Rao is a consultant working in the area of medical device investment research.
   e-mail: anilkrao@yahoo.com

NPG Journals

by Subject Area

• Chemistry

  • Chemistry
  • Drug discovery
  • Biotechnology
  • Materials
  • Methods & Protocols

• Clinical Practice & Research

  • Cancer
  • Cardiovascular medicine
  • Dentistry
  • Endocrinology
  • Gastroenterology & Hepatology
  • Methods & Protocols
  • Pathology & Pathobiology
  • Urology

• Earth & Environment

  • Earth sciences
  • Evolution & Ecology

• Life sciences

  • Biotechnology
  • Cancer
  • Development
  • Drug discovery
  • Evolution & Ecology
  • Genetics
  • Immunology
  • Medical research
  • Methods & Protocols
  • Microbiology
  • Molecular cell biology
  • Neuroscience
  • Pharmacology
  • Systems biology

• Physical sciences

  • Physics
  • Materials

by A - Z Index